Manish Patel, DO

Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation

Manish Patel

Contact Info

Mailing Address:
420 Delaware ST SE
MMC 480
Minneapolis, MN 55455

Administrative Assistant Name
Sarah Strommer

Administrative Phone

Administrative Email

Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation

Hematologist / Oncologist

MD, Medical School, Kirksville College of Osteopathic Medicine, Kirksville, MO

Residency, McGaw Medical Center of Northwestern University-Evanston, Evanston, IL

Fellowship, University of Minnesota, Minneapolis, MN

Fellowship, Winthrop University Hospital, Mineola, NY


Dr. Patel received a BS in Molecular Biology from Vanderbilt University in 1996. He then attended Kirksville College of Osteopathic Medicine, receiving a Doctor of Osteopathy degree in 2001. Dr. Patel then pursued residency in Internal Medicine at McGaw Medical Center of Northwestern University. He followed this with a clinical research fellowship at Winthrop University Hospital (Mineola, NY) from 2004-2006. In 2006 he joined the Hematology, Oncology and Transplantation fellowship at the University of Minnesota and in July 2010 became a faculty member of the Division.

Awards & Recognition

  • Beth Ann Miller Award, Mesothelioma Applied Research Foundation (2011)
  • Co-Resident of the Year, McGaw Medical Center (2001)

Professional Associations

  • Member, American Society of Clinical Oncology
  • Member, American Association of Cancer Research
  • Member, American College of Chest Physicians
  • Member, International Association for the Study of Lung Cancer



  • Patel MR, Sadiq AA, Jay-Dixon J, Jirakulaporn T, Jacobson BA, Farassati F, Bitterman PB, Kratzke RA. Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation. Int J Oncol. 2012 Feb;40(2):577-82.
  • Sadiq AA, Patel MR, Jacobson BA, Escobedo M, Ellis K, Oppegard LM, Hiasa H, Kratzke RA. Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II. Invest New Drugs. 2010 Feb;28(1):20-5.
  • Jacobson BA, De A, Kratzke MG, Patel MR, Jay-Dixon J, Whitson BA, Sadiq AA, Bitterman PB, Polunovsky VA, Kratzke RA. Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma. Br J Cancer. 2009 Aug 4;101(3):424-31.
  • Patel MR, Jacobson BA, De A, Frizelle SP, Janne P, Thumma SC, Whitson BA, Farassati F, Kratzke RA. Ras pathway activation in malignant mesothelioma. J Thorac Oncol. 2007 Sep;2(9):789-95.
  • Whitson BA, Jacobson BA, Frizelle S, Patel MR, Yee D, Maddaus MA, Kratzke RA. Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award. Ann Thorac Surg. 2006 Sep;82(3):996-1001; discussion 1001-2.



  • Hematology/Oncology


Masonic Cancer Center

Board Certifications

  • Medical Oncology
  • Internal Medicine

Clinical Interests

Thoracic oncology; Experimental therapies; Head and neck cancer; Mesothelioma